Joseph Warusz named vice-president of administration and controller at Soligenix
This article was originally published in Scrip
Executive Summary
Soligenix, a late-stage biopharmaceutical company, has appointed Joseph Warusz vice-president of administration and controller. He has over 28 years' experience of financial management, and previously held financial positions with companies including Amicus Therapeutics, Orchid Cellmark and NexMed.
You may also be interested in...
Almirall launches Constella in six European markets
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira raises $35m in series B
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis ups public offering to $240m
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.